This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Bangalore Bioinnovation Centre | |
|---|---|
| Name | Bangalore Bioinnovation Centre |
| Formation | 2013 |
| Type | Research and incubator |
| Headquarters | Bangalore, Karnataka, India |
| Region served | Karnataka, India |
| Leader title | Director |
| Parent organization | Karnataka Biotechnology and Information Technology Departments |
Bangalore Bioinnovation Centre is a translational research and incubation hub located in Bangalore, Karnataka, India, established to accelerate biotechnology entrepreneurship and product development. The centre provides shared laboratory space, mentorship, and technology platforms to bridge the gap between academic research and commercialisation, engaging universities, hospitals, and industry stakeholders. It operates within a regional biotech innovation ecosystem and interfaces with international funding and regulatory institutions.
The centre was founded in 2013 as part of a state-level initiative linking the Departments of Karnataka, Department of Biotechnology (India), National Biopharma Mission, and regional science parks such as Bangalore Life Sciences Cluster and Indian Institute of Science spinouts. Early governance involved stakeholders from Karnataka Biotechnology and Information Technology Services, Biocon Limited, Bharat Biotech International Limited, Serum Institute of India, and academic partners including Indian Institute of Science, Jawaharlal Nehru University, Indian Institute of Technology Madras, and National Centre for Biological Sciences. Initial funding and policy support drew on schemes from Department of Science and Technology (India), Bill & Melinda Gates Foundation, DBT-BIRAC and state innovation missions such as Atal Innovation Mission. Over the first decade, the centre expanded connections to incubators like NSRCEL and accelerator networks including T-Hub and Startup India initiatives, while interacting with regulatory agencies including Central Drugs Standard Control Organization and Indian Council of Medical Research.
The centre houses wet labs, biosafety level certified suites, and analytical platforms that serve academic innovators and small enterprises. Equipment inventories include high-throughput sequencers from suppliers comparable to platforms used at National Centre for Biological Sciences and mass spectrometers analogous to installations at Indian Institute of Science core facilities. Shared instrumentation mirrors resources found in translational hubs like Centre for Cellular and Molecular Platforms and technical service providers associated with Biocon Biologics and Syngene International. Onsite infrastructure supports regulatory-compliant workflows interacting with institutions such as Central Drugs Standard Control Organization and clinical trial centres linked to St. John’s Medical College and Christian Medical College, Vellore. The facility design accommodates collaborations with entrepreneurial ecosystems around Electronic City, Bangalore and research clusters near Hebbal and Whitefield.
Programs emphasize translational pipelines in areas including diagnostics, vaccines, biologics, agricultural biotechnology, and bioinformatics. Project portfolios align with national missions like National Biopharma Mission and priorities from agencies such as Department of Biotechnology (India) and Indian Council of Medical Research. The centre runs thematic cohorts modeled on consortia such as Genome India Project and collaborates with translational platforms like Centre for Cellular and Molecular Platforms and computational groups at IISc and Indian Institute of Technology Delhi. Training programs reference curricula and partnerships with institutions like NCBS, Christel House India, and professional networks such as Association of Biotechnology Led Enterprises. Innovation challenges and hackathons have been run in coordination with organizations akin to Startup India and accelerators such as India Accelerator.
Incubation services include laboratory access, business mentoring, regulatory strategy assistance, and investor readiness support drawing on networks similar to Indian Angel Network, Accel Partners, and Sequoia Capital India. Start-up cohorts have benefitted from mentoring by entrepreneurs from Biocon Limited, Serum Institute of India, and academics from Indian Institute of Science. The centre hosts demo days and pitch events that attract participation from venture capital firms such as Kalaari Capital and corporate partners like Wipro, Tata Group, and pharmaceutical firms comparable to Cipla and Lupin. Legal and intellectual property guidance is informed by practices from technology transfer offices at IISc and IIT Madras.
Strategic partnerships span universities, hospitals, industry, and international agencies. Academic partners include Indian Institute of Science, National Centre for Biological Sciences, IIT Madras, and Jawaharlal Nehru University; clinical partnerships include St. John’s Medical College and private hospitals in Bangalore. Industry collaborators range from biopharma players like Biocon and Bharat Biotech to contract research organisations resembling Syngene International. International linkages have been developed with funding and technical partners analogous to Bill & Melinda Gates Foundation, Wellcome Trust, and multilateral initiatives such as Global Health Innovative Technology Fund.
Funding sources combine state allocations from the Government of Karnataka, central grants from Department of Biotechnology (India) and Department of Science and Technology (India), programmatic support from DBT-BIRAC, competitive awards from foundations like Bill & Melinda Gates Foundation and Wellcome Trust, and revenue from paid services and tenancy. Governance frameworks include advisory boards with representatives from institutions such as Indian Institute of Science, Biocon Limited, Indian Council of Medical Research, and state innovation agencies like Karnataka Biotechnology and Information Technology Services.
The centre has incubated multiple biotechnology start-ups that progressed to seed and series funding rounds from investors similar to Indian Angel Network and Sequoia Capital India, and facilitated prototype-to-clinic transitions engaging regulators like Central Drugs Standard Control Organization. Projects emerging from the centre have contributed to diagnostic development during public health responses involving Indian Council of Medical Research coordination and collaborated on vaccine and therapeutic research trajectories resonant with efforts by Bharat Biotech and Serum Institute of India. The centre’s role in building capacity mirrors outcomes seen at translational hubs such as Centre for Cellular and Molecular Platforms and regional innovation ecosystems like Bangalore Technology Summit, enhancing linkages among academia, industry, and clinical stakeholders.
Category:Biotechnology in India Category:Research institutes in Bangalore